Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice

Induction of systemic immune responses and reversion of immunosuppression in the tumor microenvironment by a therapeutic vaccine for cervical cancer

(2020) Yuxin Che et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Prevention and treatment of cervical cancer by a single administration of human papillomavirus peptide vaccine with CpG oligodeoxynucleotides as an adjuvant in vivo

(2019) Yang Yang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Human papillomavirus (HPV) vaccination: from clinical studies to immunization programs

(2019) Raúl Murillo et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus

(2019) Edison J. Mavundza et al.   Human Vaccines & Immunotherapeutics

Therapeutic HPV vaccines

(2018) Gemma Hancock et al.   BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY

Optimization of the Linker Length of Mannose-Cholesterol Conjugates for Enhanced mRNA Delivery to Dendritic Cells by Liposomes

(2018) Fazhan Wang et al.   Frontiers in Pharmacology

Chemokines as adjuvants for immunotherapy: implications for immune activation with CCL3

(2017) Teilo H. Schaller et al.   Expert Review of Clinical Immunology

Endogenous and tumour-derived microRNAs regulate cross-presentation in dendritic cells and consequently cytotoxic T cell function

(2016) Siambi Kikete et al.   CYTOTECHNOLOGY

Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma

(2015) Yan Zhao et al.   BIOMATERIALS

Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected

(2015) Douglas Marvel et al.   JOURNAL OF CLINICAL INVESTIGATION

Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells

(2015) Sanja Stevanović et al.   JOURNAL OF CLINICAL ONCOLOGY

Dynamic Alterations in the CaV1.2/CaM/CaMKII Signaling Pathway in the Left Ventricular Myocardium of Ischemic Rat Hearts

(2014) Yan Zhao et al.   DNA AND CELL BIOLOGY

Biomaterials for Nanoparticle Vaccine Delivery Systems

(2014) Preety Sahdev et al.   PHARMACEUTICAL RESEARCH

Peptide-based vaccines for cancer therapy

(2014) Giorgio Parmiani et al.   Human Vaccines & Immunotherapeutics

Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response

(2014) Genevieve M Weir et al.   OncoImmunology

Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis

(2013) Zhenghong Xu et al.   JOURNAL OF CONTROLLED RELEASE

Tumor Burden Talks in Cancer Treatment with PEGylated Liposomal Drugs

(2013) Yi-Yu Lin et al.   PLoS One

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy

(2013) Christel Devaud et al.   OncoImmunology

Decisions About Dendritic Cells: Past, Present, and Future

(2012) Ralph M. Steinman   Annual Review of Immunology

Molecular Mechanisms of Treg-Mediated T Cell Suppression

(2012) Angelika Schmidt et al.   Frontiers in Immunology

Cationic liposomes as vaccine adjuvants

(2011) Dennis Christensen et al.   Expert Review of Vaccines

FOXO-dependent regulation of innate immune homeostasis

(2010) Thomas Becker et al.   NATURE

Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity

(2008) Syed M. Faisal et al.   VACCINE